4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000168
EVP, Chief Reg. & Quality Off. sold 2,175 shares at $460.00 ($1,000,500)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-03 | Sale : show line 1 in the form 10b5-1 | −2,175 | $460.00 | $1,000,500 | 49,098 | D |
| Open-market sales · 2,175 sh · avg $460.00 · $1,000,500 | ||||||
Loading xslF345X05/wk-form4_1717618128.xml…